Coping with a delayed diagnosis of PNH

Misdiagnosis and delays in diagnosis are a challenge for many people living with paroxysmal nocturnal hemoglobinuria.

Updated on August 17, 2026.

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disorder that causes the destruction of blood cells, including red blood cells, white blood cells, and platelets. The severity of the condition can range from mild to life-threatening, with complications that can include blood clots, bone marrow failure, and chronic kidney disease.

PNH can be a challenging condition to live with. Even cases that are considered mild can cause fatigue, headaches, chest pain, rapid heartbeat, and reduced capacity for exercise. Management typically requires the continuous use of medications, which require frequent dosing and high out-of-pocket costs. Even with medications, breakthrough episodes can occur.

Another challenge for many people is a delay in diagnosis. Symptoms vary from person to person. Symptoms also overlap with other conditions, some that are more common than PNH.

Many people with PNH visit multiple healthcare providers before receiving an accurate diagnosis. This is frustrating for multiple reasons—ongoing symptoms, additional healthcare costs, and in some cases, significant or serious complications.

If you or a loved one has experienced a delay in diagnosis of PNH, it may help to keep the strategies below in mind.

Focus on treatment

When you’ve experienced a delay in diagnosis, it’s normal to feel some amount of doubt or mistrust about your current diagnosis or the healthcare providers you are working with. This is common among people with rare diseases like PNH.

While it’s important to acknowledge these feelings, it’s also important that you do not let these feelings interfere with treatment.

If you haven’t already, find a hematologist with experience in treating PNH or rare bone marrow disorders. Ideally, the treatment of PNH should be a coordinated effort between a hematologist and a primary care provider. A care team can include other specialists depending on your treatment needs.

How is PNH treated?

Complement inhibitors are the main treatment for PNH. These are medications that prevent the breakdown of blood cells. These are taken as oral medications or self-administered infusions, depending on the specific drug. Always discuss how a medication works and potential side effects with a healthcare provider.

Blood transfusions and blood thinners may also be needed at times. Some people with PNH require iron and/or folic acid supplementation. Supplements should always be taken under the guidance of a healthcare provider.

PNH can potentially be cured with an allogenic stem cell transplant (bone marrow transplant), but this procedure carries a high risk of serious side effects and requires a matching stem cell donor. It is only recommended in cases of severe, life-threatening PNH.

Keep learning about PNH

Patient education is an important part of treatment for rare disorders. It can also be a challenge. Compared to more common conditions, there tends to be less information available about rare diseases. Information that is available can contain complex medical terminology.

Here are a few strategies for learning about a diagnosis:

  • Ask your healthcare provider if they have information that you can take with you or if they can recommend websites or organizations where you can learn more.
  • Set aside a small amount of time each week to read about PNH. Keep a reading list of websites, articles, guidelines, or other online resources.
  • Keep a list of what you want to discuss with your healthcare team. Write down questions and anything you want them to explain to you. No question or topic is too basic.
  • Look for support groups or online communities where you can connect with other people who are living with PNH.

If you have had a long or eventful diagnostic journey with PNH, spend some time thinking about the experiences you had along the way. Think about interactions you had with healthcare providers, times you felt frustrated or disappointed, things you wish you had done differently. Think about how these experiences can guide your management and treatment going forward.

Article sources open article sources

MedlinePlus Genetics. Paroxysmal nocturnal hemoglobinuria. February 24, 2024.
National Organization for Rare Disorders. Paroxysmal Nocturnal Hemoglobinuria. May 29, 2024.
Nischay Shah and Harshil Bhatt. Paroxysmal Nocturnal Hemoglobinuria. StatPearls. July 31, 2023.
Bruno Fattizzo, Francesco Versino, and Wilma Barcellini. Breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria throughout clinical trials: from definition to clinical practice. Blood, 2025. Vol. 146, No. 4.
Adam Bowen, Miller Lantis, et al. Diagnostic delays and misdiagnosis patterns in paroxysmal nocturnal hemoglobinuria. Blood, 2025. Vol. 146, Suppl. 1.
Meryem Bektas, Catherine Copley-Merriman, et al. Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease.
Meryem Bektas, Catherine Copley-Merriman, et al. Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease. Jounral of Managed Care + Specialty Pharmacy, 2020. Vol. 26, Suppl. 12-b.
Marc Bienz andChristopher J. Patriquin. The varieties of therapeutic experience: navigating treatment options for patients with PNH. Hematology The American Society of Hematology Program, 2025. Vol. 2025, No. 1.
Juan Benito-Lozano , Greta Arias-Merino, et al. Psychosocial impact at the time of a rare disease diagnosis. PLOS ONE, 2023. Vol. 18, No. 7.
Diana Deiz Gasper. Paroxysmal Nocturnal Hemoglobinuria (PNH) Care Team. Rare Disease Advisor. November 23, 2022.
Gloria F. Gerber. Paroxysmal Nocturnal Hemoglobinuria (PNH). Merck Manual Professional Version. April 2026.
Cleveland Clinic. Paroxysmal Nocturnal Hemoglobinuria. May 28, 2026.
Una Stenberg, Lydia Westfal, et al. A scoping review of health literacy in rare disorders: key issues and research directions. Orphanet Journal of Rare Diseases. September 6, 2024.
Christopher Schimming. 8 tips for coping with a serious diagnosis. Mayo Clinic Health System. April 18, 2022.

More On

What does the term personalized medicine mean to you?

video

What does the term personalized medicine mean to you?
Vinod Khosla, technology entrepreneur, explains that personalized medicine is tailored medicine, created specifically for an individual's specific sys...
ATTR cardiomyopathy: gene silencers and gene stabilizers

article

ATTR cardiomyopathy: gene silencers and gene stabilizers
A look at two types of disease-modifying therapies used in the treatment of ATTR cardiomyopathy.
Why use human cells for trials rather than human beings?

video

Why use human cells for trials rather than human beings?
Human cells are used in trials to avoid putting humans at risk, says HealthMaker Francis Collins, MD, PhD, director of the National Institutes of Heal...
What is epigenomics?

video

What is epigenomics?
In this video, Eric Green, MD, Director of the National Human Genome Research Institute, explains epigenomics and how it's used to measure how our bod...
How can genomics be used to tailor cancer treatment?

video

How can genomics be used to tailor cancer treatment?
Eric Green, MD, Director of the National Human Genome Research Institute, explains how genomics can be used to not only classify forms of cancer but t...